2005 Press Releases

• Tranzyme Pharma Appoints New Vice President of Clinical and Regulatory Affairs

  September 20, 2005

• Tranzyme Pharma’s Ghrelin Agonist Demonstrates a Unique Selectivity Profile for the Treatment of Gastrointestinal Disorders

  July 6, 2005

• FierceBiotech Honors Tranzyme Pharma as One of the “Fierce 15” Biotech Companies of 2005

  June 21, 2005

• Tranzyme Pharma Presents Positive Preclinical Efficacy Data for its Lead GI Therapeutic, TZP-101

  May 19, 2005

• Tranzyme Pharma Completes US$32 Million Financing

  May 13, 2005

Archives

• 2009 Press Releases
• 2008 Press Releases
• 2007 Press Releases
• 2006 Press Releases
• 2005 Press Releases
• 2004 Press Releases
• 2003 Press Releases